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Abstract 
Mg deficiency increases the concentration of Zn in the liver. We investigated the effect of Mg 
deficiency on the expression of Zn-regulating factors such as Zn transporters and metallothionein 
(MT) in the rat liver. Because Ca deficiency alleviates some of the effects of Mg deficiency, we 
also investigated the interactions associated with Ca and Mg deficiencies. Growing male rats were 
given a control diet, an Mg-deficient diet, a Ca-deficient diet, and an Mg- and Ca-deficient diet for 
3 weeks. Mg and Ca deficiencies additively increased the mRNA levels of MT-1 and MT-2, the MT 
protein concentration, and the concentration of Zn in the liver. The hepatic level of Zip14 mRNA 
increased with Mg deficiency but not with Ca deficiency. The dietary treatments did not affect the 
mRNA levels of other Zn transporters such as Zip1, Zip5, ZnT1, ZnT5, and ZnT6 in the liver. Ca 
deficiency was found to decrease the amount of femoral Zn and increase the serum Zn 
concentration. This did not occur in the case of Mg deficiency. These results suggest that Mg 
deficiency enhances hepatic Zn uptake by up-regulation of Zip14 expression and increases the 
hepatic Zn concentration, leading to the enhancement of the MT expression. Ca deficiency causes a 
transfer of Zn from the bone to the liver, which increases the hepatic Zn concentration and, in turn, 
up-regulates the expression of MT. Because Mg and Ca deficiencies increase the hepatic Zn 









Mg deficiency is known to disturb Zn metabolism. Mg deficiency increases the concentration of Zn 
in the liver(1-3) while the Zn concentration decreases in the testis(1) and the heart(2). Although the 
liver plays a central role in the metabolism of Zn, it has not been clarified how Mg deficiency 
enhances Zn accumulation in the liver. 
Metallothionein (MT) is a cysteine-rich, low molecular weight protein consisting of four 
isoforms. Isoforms MT-1 and MT-2 are expressed in the liver(4) and are known to have diverse 
functions in Zn homeostasis and in protection against heavy metal toxicity and oxidative stress(5). 
The expression of MT is up-regulated by metals, including Zn, and by oxidative stress in the liver(6). 
Because Mg deficiency is known to induce oxidative stress in the liver(3,7,8), it has been speculated 
that oxidative stress caused by Mg deficiency would increase the hepatic Zn concentration through 
up-regulation of MT expression(3). 
Solute carrier family 39 members such as Zip1(9), Zip5(10), and Zip14(11) and solute carrier 
family 30 members such as ZnT1(12), ZnT5(13), and ZnT6(14) are expressed in the liver. Solute carrier 
family 39 members increase the cytosolic Zn concentration by importing Zn into the cytosol from 
the extracellular fluid or intracellular organelles, and solute carrier family 30 members decrease the 
cytosolic Zn concentration by promoting Zn efflux from the cytosol(15). Thus, these transporters 
affect Zn metabolism in the liver. However, the effect of Mg deficiency on the expression of Zn 
transporters has not been reported. 
Mg frequently acts as a natural Ca antagonist(16), and Ca deficiency was reported to ameliorate 
some of the effects of Mg deficiency(17). Therefore, simultaneous Ca and Mg deficiency possibly 
suppresses Zn accumulation observed in the liver of Mg-deficient animals.  
We performed an investigation to clarify the effects of Mg and Ca deficiencies, and the effects 
of their interactions on the Zn concentration and the expression of MT and Zn transporters in rat 
liver. 
Materials and methods 
Animals and diets 
Twenty-four male specific pathogen-free Sprague-Dawley rats aged 4 weeks were purchased from 
SLC Japan (Shizuoka, Japan) and cared for according to the Guide for the Care and Use of 
Laboratory Animals (Animal Care Committee, Kyoto University). The rats were individually 
housed in stainless steel cages in a temperature-, humidity- and light-controlled room (24°C, 60%, 
and 12-h light/dark cycle, respectively). All rats were fed the AIN-93G diet(18) for a 5-d adaptation 
period. Then the animals were divided into 4 groups of 6 rats as a 2 × 2 factorial arrangement (2 
dietary Mg levels and 2 dietary Ca levels): one group was given the control diet, another group was 
fed an Mg-deficient (MGD) diet, another group was fed a Ca-deficient (CAD) diet, and the 
remaining group was fed an Mg- and Ca-deficient (MCD) diet. These diets were prepared on the 
basis of the AIN-93G diet(18) with Mg- and Ca-free AIN-93G mineral premix. MgO was added at 
26.1 mmol/kg for the control and CAD diets at the expense of cornstarch. CaCO3 was added at 130 
mmol/kg for the control and the MGD diets and at 13 mmol/kg for the CAD and the MCD diets. 
The dietary concentrations of Mg, Ca, and Zn are shown in Table 1. Animals were pair-fed with 
their respective experimental diets adjusted to match the feed intake of the MGD group. The rats 
were allowed free access to demineralized water for 3 weeks. 
 
Data and sample collection 
We measured the feed intake and body weight during the experiment. Feed efficiency was 
calculated from the ratio of weight gain to feed intake. Inflammatory skin lesions were evaluated by 
the inflammatory score(19) with a slight modification based on the following criteria: 0 points, no 
skin lesion; 1 point, hyperemia of one ear accompanied by swelling; 2 points, hyperemia of both 
ears accompanied by swelling; 3 points, inflammation of one ear, including slough; 4 points, 
inflammation of both ears, including slough; 5 points, inflammation of both ears and tail. 
Under isoflurane anesthesia, a blood sample was obtained from the abdominal aorta with a 
plastic syringe at the end of the experiment. Serum was separated by centrifugation at 3,000 × g for 
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30 min at 4°C. The left femur was removed, cleaned of adhering tissues, and weighed. The serum 
and femur samples were stored at -20°C until analyses. The liver was promptly excised, weighed, 
washed with ice-cold isotonic saline, placed in liquid nitrogen, and stored at -80°C until analyses.  
 
Determination of minerals, thiobarbituric acid-reactive substances, and MT protein 
The liver, femur, serum, and diet samples were wet-digested with trace-element-grade nitric acid 
and hydrogen peroxide (Wako Chemicals, Osaka, Japan). Then we determined the Mg, Ca, and Zn 
concentrations in the serum and tissue samples with an atomic absorption spectrophotometer 
(AA-6600F; Shimadzu, Kyoto, Japan). 
The liver samples were homogenized in chilled saline and the homogenate was centrifuged at 
105,000 × g for 30 min at 4°C (CS100X, Hitachi Koki, Tokyo, Japan). The concentration of 
thiobarbituric acid-reactive substances (TBARS) in the supernatant was determined using a 
commercial kit (OXI-TEK TBARS Assay Kit; ZeptoMetrix, Buffalo, NY, USA) according to the 
instruction manual. 
The total hepatic MT protein concentration was determined according to the Cd-Chelex 
method(20,21). Briefly, the liver samples were homogenized in a 250-mM sucrose solution on ice and 
centrifuged at 105,000 × g for 60 min at 4°C. The supernatant was mixed with 0.55-mM CdCl2 in 
20-mM Tris-HCl buffer (pH 8), incubated for 10 min at room temperature, and then heated at 
100°C for 3 min. After cooling, the mixture was centrifuged at 8,000 × g for 10 min at 4°C. Then, 
16 mg/mL of the ion-exchange resin (Chelex 100; Bio-Rad Japan, Tokyo, Japan) was added to the 
supernatant and shaken for 30 min. The resin and precipitate were removed by centrifugation at 
8,000 × g for 10 min at 4°C. The Cd concentration in the supernatant was determined as the form 
binding to MT by an inductively-coupled plasma mass spectrometer (Elan 6000; Perkin Elmer, 
Waltham, MA, USA). The protein concentration of MT was calculated using a molecular weight of 
6,600 for MT and the assumption that 7 g of Cd atoms corresponds to 1 mol of MT(20). 
 
RNA preparation and quantitative RT-PCR 
Total RNA was extracted from liver samples with TRIzol reagents (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer’s protocol. Absorbance at 260 nm was measured to quantify the 
RNA concentration, and simultaneously the ratio of absorbance at 260 nm to that at 280 nm was 
monitored to assess the purity of the RNA. Quantitative RT-PCR was carried out as described 
previously(22). The gene transcripts of MT-1, MT-2, Zip1, Zip5, Zip14, ZnT1, ZnT5, ZnT6, and 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) were amplified by cDNA-specific primers 




Statistical analyses (except for the inflammation score) were performed using SAS statistical 
software (version 9.1; SAS Institute, Cary, NC, USA). The results were expressed as means with 
SEM. Data reflecting mRNA levels were log-transformed to provide an approximation of a normal 
distribution before analysis. The data were analysed as a 2 × 2 factorial using the GLM procedure. 
The statistical model included the main effects of dietary Mg, dietary Ca and their interaction. 
When an interaction was significant, the significant differences between means were evaluated 
using a multiple comparison procedure (Student-Newman-Keuls) or the significant difference 
between 2 means was evaluated using the two-sided t-test. The inflammation score data were 
expressed as means with SEM, and a significant difference between groups was determined each 
day by the Steel-Dwass test(23). When all rats in more than two groups had no inflammation, the 
data of one group were adopted as representative data in the statistical analysis because of 




No skin lesions were observed in the control group and in the CAD group throughout the 
experiment. The inflammation score in the MGD group was significantly higher than that in the 
MCD group on day 4 (P < 0.05); this score peaked on day 5 and had essentially disappeared by day 
13 (Fig. 1). Although two rats in the MCD group had a relatively high score on the last 2 d, the 
inflammation score did not differ significantly among the control, CAD, and MCD groups 
throughout the experiment. 
The dietary treatments did not significantly affect the final body weight (Table 3). Ca 
deficiency and Mg deficiency did not affect body weight gain. However, interaction between Ca 
deficiency and Mg deficiency was significant (P = 0.029). Body weight gain did not differ among 
the control, CAD, and MCD groups but body weight gain was significantly lower in the MGD 
group than in the other groups (P < 0.05). The dietary treatments did not affect the feed intake 
because the animals were pair-fed. Therefore, feed efficiency was similarly affected as body weight 
gain by the dietary treatments. 
The serum Mg concentration was significantly decreased by Mg deficiency (P < 0.001) but 
was significantly increased by Ca deficiency (P < 0.001) (Table 4). Interaction between Ca 
deficiency and Mg deficiency was also significant (P = 0.008). The serum Mg concentration was 
significantly lower in the Mg-deficient groups than in the Mg-sufficient groups (P < 0.05). The 
CAD group had a significantly higher serum Mg concentration than the control group (P < 0.05). 
Although the multiple comparison analysis showed that the serum Mg concentration did not differ 
significantly between the MCD group and the MGD group, the Mg concentration was 40% higher 
(P = 0.01 by t-test) in the MCD group than in the MGD group. The dietary treatments did not affect 
the serum Ca concentration. The dietary Ca concentration had a significant effect on the serum Zn 
concentration (P < 0.001); Ca deficiency significantly increased the serum Zn concentration. On the 
other hand, Mg deficiency did not affect the serum Zn concentration and did not affect the increase 
in serum Zn concentration caused by Ca deficiency. 
Ca deficiency significantly decreased the femoral weight (P = 0.009); however, Mg deficiency 
did not affect either the femoral weight or the reduction of femoral weight caused by Ca deficiency. 
The amount of femoral Mg was significantly decreased by either Mg or Ca deficiency (P < 0.001). 
An interaction between Ca deficiency and Mg deficiency was also significant (P < 0.001). The 
Mg-deficient groups had significantly smaller amounts of femoral Mg than the Mg-sufficient 
groups (P < 0.05). The femoral Mg was significantly lower in the CAD group than in the control 
group (P < 0.05). Additionally, the amount of Mg was significantly lower in the MCD group than in 
the MGD group (P < 0.05). Ca deficiency significantly affected the amount of femoral Ca (P < 
0.001); Ca deficiency decreased the amount of Ca. Mg deficiency did not affect the amount of 
femoral Ca and the extent of decreased femoral Ca by Ca deficiency. The amount of femoral Zn 
was significantly decreased by Ca deficiency (P = 0.026) but was slightly increased by Mg 
deficiency (P = 0.007). Interaction between Ca deficiency and Mg deficiency was not observed. 
The dietary treatments did not affect the liver weight (Table 5). Either Mg or Ca deficiency 
significantly increased the Zn concentration in the liver (Mg deficiency, P = 0.009; Ca deficiency,   
P = 0.004). An interaction was not observed, indicating that Mg and Ca deficiencies additively 
increase the hepatic Zn concentrations. Because the dietary treatments did not affect liver weight, 
the amount of hepatic Zn was similarly affected as its concentration by the dietary treatments. 
Either Mg or Ca deficiency increased the concentration of MT protein in the liver (Mg deficiency, P 
= 0.001; Ca deficiency, P = 0.003). An interaction was not observed, indicating that Mg and Ca 
deficiencies additively increase the MT protein concentrations. The hepatic TBARS concentration 
was increased by Mg deficiency (P = 0.034), but Ca deficiency affected neither the hepatic TBARS 
concentration nor the extent of increased TBARS concentration by Mg deficiency.  
The mRNA level of MT-1 was significantly increased by either Mg or Ca deficiency in the 
liver (Mg deficiency, P < 0.001; Ca deficiency, P = 0.001) and an interaction was not observed 
(Table 6). The mRNA level of MT-2 was significantly increased by either Mg or Ca deficiency in 
the liver (P < 0.001) and an interaction was not observed. These results indicate that Mg and Ca 
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deficiencies additively increase the mRNA levels of MT-1 and MT-2. Mg deficiency was found to 
significantly increase the hepatic level of Zip14 mRNA (P = 0.014) but Ca deficiency affected 
neither the mRNA level of Zip14 nor the increase in mRNA level caused by Mg deficiency. The 
dietary treatments did not affect the mRNA levels of Zip1, Zip5, ZnT1, ZnT5, and ZnT6, indicating 
that the increased hepatic Zn concentration caused by Ca or Mg deficiency is not related to the 
mRNA levels of these transporters. 
 
Discussion 
Although Mg deficiency did not affect the serum Zn concentration, Mg deficiency increased the 
hepatic Zn concentration and the Zip14 mRNA level without affecting the mRNA levels of the 
other Zn transporters. Zip14 imports Zn into the cytosol through the plasma membrane in the 
liver(15). The suppression of Zip14 expression by a specific small interfering RNA decreases the 
extent of Zn uptake by the hepatocytes(24), and the up-regulation of Zip14 expression is considered 
to increase the extent of hepatic Zn accumulation(11). These results suggest that Mg deficiency 
increases Zn uptake by the liver through up-regulation of Zip14 expression at the mRNA level. 
Hepatic expression of Zip14 is transcriptionally enhanced by interleukin-1β(25) and interleukin-6(11). 
These cytokine concentrations in the plasma were reported to increase in rats fed a low-Mg diet for 
3 weeks(26). It is possible that the elevation of these cytokine levels up-regulates mRNA expression 
of Zip14 in the livers of Mg-deficient rats. 
Mg deficiency increases the concentration of MT protein with increasing mRNA levels of 
MT-1 and MT-2 in the liver. MT-1 transcription is enhanced by increased cytosolic Zn 
concentrations and oxidative stress(6). Thus, we consider that the expressions of MT mRNA and MT 
protein are enhanced by an increased Zn uptake through up-regulation of Zip14 expression in the 
liver of Mg-deficient animals. This is supported by reports showing that over-expression of Zip14 
increased the mRNA expression of MT-1 via an increased Zn uptake in HEK 293T cells(11) and that 
its down-regulation decreased the expression of MT-1 mRNA through suppression of Zn uptake in 
cultured hepatocytes(24). Mg deficiency increased hepatic Zn concentration by 20% and increased 
hepatic MT expression by 40%. An experiment using subcutaneous injection with Zn indicated that 
MT concentration highly and linearly correlated with Zn concentration in the liver of rats and that 
MT concentration largely responded to changes in Zn concentration(27). Therefore, we consider that 
the increase in Zn concentration is enough to explain the enhancement of MT expression in the liver 
of Mg-deficient rats. Additionally, Mg deficiency induced oxidative stress, which is reflected by 
increased TBARS concentrations measured in this study. This is supported by previous reports(3,7,8). 
Therefore, it is also likely that oxidative stress partly contributes to the up-regulation of expression 
of MT mRNA in the liver of Mg-deficient animals.  
Hepatic Zn concentration is 2-fold lower in MT-1 and MT-2 null mice than in wild-type mice 
when excess Zn is provided, and 72% of the total Zn in the liver is associated with MT in the 
wild-type mice(28). Therefore, the large difference of MT expression probably affects the Zn 
concentration in the liver. On the other hand, it was reported that the total Zn concentration was not 
changed in rat liver even when Zn-bound MT was increased by 5- and 7-fold by cold stress and 
treatment with CCl4, respectively(29). The administration of lipopolysaccharides was reported to 
cause approximately a 12-fold increase in the mRNA level of MT-1 in mouse liver but did not affect 
the total Zn concentration(30). Mg deficiency was found to increase the expression of MT protein 
and MT-1 mRNA by 40% and 7-fold, respectively. These results suggest that the increase in the MT 
expression is not enough to increase the Zn concentration in the liver of Mg-deficient animals. The 
increase in the MT expression does not contribute significantly to increasing the Zn concentration. 
We consider that Mg deficiency increases Zn uptake by enhancing Zip14 expression in the liver, 
and that MT expression is up-regulated by an increased Zn concentration and possibly by oxidative 
stress. Then, MT traps Zn loaded to the liver by Mg deficiency.  
The levels of circulating Zn were reported to decrease immediately after inducing Zip14 
expression in the mouse liver(11) and MT expression in the rat liver(29). However, the up-regulation 
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of Zip14 mRNA and MT protein expression did not affect serum Zn concentration in the 
Mg-deficient rats. These results suggest that the serum Zn concentration is not affected by chronic 
up-regulation of expression of Zip14 or MT in Mg-deficient rats. An adaptive mechanism of Zn 
may prevent hypozincemia in Mg-deficient rats with chronically enhanced expression of Zip14 or 
MT. 
In contrast to the observations in cases of Mg deficiency, Ca deficiency was found to increase 
the serum Zn concentration along with reducing the amount of femoral Zn. Bone is a major 
reservoir of Zn in the body, and Ca deficiency accelerates the release of Zn from bones. This is 
accompanied by bone resorption(31). A low Ca diet was reported to increase the plasma Zn 
concentration(32). This is supported by the present results. Therefore, we suggest that Ca deficiency 
increases the serum Zn concentration through stimulation of bone resorption in the present 
experiment. The present results indicated that Ca deficiency increased the concentrations of Zn and 
MT in the liver. Furthermore, Ca deficiency increased the mRNA levels of MT-1 and MT-2 in the 
liver without affecting the mRNA levels of Zn transporters. As mentioned above, MT concentration 
highly and linearly correlated with Zn concentration in the liver of rats and that MT concentration 
largely responded to changes in Zn concentration(27). These results suggest that the enhanced Zn 
supply to the liver increases the hepatic Zn concentration in Ca-deficient rats, leading to the 
up-regulation of MT expression through increases in the mRNA expressions of MT-1 and MT-2. 
Then hepatic MT traps Zn supplied from bone in Ca-deficient animals.  
Reductions in the dietary Zn beyond the capacity to maintain homeostasis lead to the 
utilization of Zn from pools located in the bone and the liver(33), and hepatic MT serves as a Zn 
reservoir that can be utilized when Zn is deficient(28). The amount of hepatic Zn was 0.68 µmol 
higher in the CAD group than in the control group. The amount of Zn in the left femur was 0.25 
μmol lower in the CAD group than in the control group; femoral Zn was 17% lower in the CAD 
group than in the control group. According to the equation of House and Wastney(34), the amount of 
whole bone Zn was calculated to be 23 µmol in the rats weighing 177 g. This body weight 
corresponds to the final mean body weight for both groups. Therefore, Zn loss from the whole bone 
was estimated to be 3.9 µmol (23 µmol multiplied by 0.17) during Ca deficiency based on the 
assumption that each bone responds to Ca deficiency in a similar manner as the femur. These results 
show that the increase in hepatic Zn corresponds to 17.4% (0.68 µmol divided by 3.9 µmol) of Zn 
loss from the skeletal tissues. This suggests that the liver only partly saves the released Zn from the 
bone during periods of Ca deficiency. 
Skin lesions are a clinical sign of inflammation in Mg-deficient rats(35). Mg deficiency-induced 
skin lesions were observed to appear shortly after the initiation of the experiment. This was resolved 
by simultaneous Ca deficiency. Additionally, Mg deficiency reduced weight gain and feed 
efficiency, which was also alleviated by simultaneous Ca deficiency. These results indicate that Ca 
deficiency rescues the effects of Mg deficiency on inflammation and growth retardation. Mg acts as 
a natural Ca antagonist(16) and the reduction of the extracellular ratio of Mg to Ca was reported to 
lead to an inflammatory response(36). The dietary restriction of Ca with hypocalcemia was reported 
to suppress the incidence of skin lesions in Mg-deficient rats, suggesting that hypocalcemia could 
be beneficial by decreasing external Ca availability and Ca entry, and thus, decreasing the 
intracellular Ca concentration in Mg-deficient animals(17). On the other hand, Ca deficiency did not 
affect the serum Ca concentration in the present experiment probably because Ca levels in 
Ca-deficient diets were 20-fold higher in the present experiment than in the above-cited report(17). 
Therefore, it is unlikely that the amelioration of skin lesions and growth retardation are related to 
the reduction of the antagonistic effect of extracellular Mg on Ca entry in the present experiment. 
Bones hold the major pool of Mg in the body and release Mg in response to Mg deficiency(37). This 
is supported by the present results, which indicate that Mg deficiency causes a significant decrease 
in the femoral Mg level without affecting the femoral Ca level. Furthermore, the required dietary 
Mg decreases linearly with a reduction in dietary Ca in rats fed with low Mg diets (based on the 
recovery body weight gain)(38). The restriction of dietary Ca decreases the amount of femoral Mg 
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and increases the serum Mg concentration, regardless of the dietary Mg level in the present 
experiment. This suggests that the supply of Mg from the bone to the soft tissues is enhanced by Ca 
deficiency even in Mg-deficient animals. We suggest that Ca deficiency ameliorates Mg deficiency 
by increasing the Mg supply from bone. This leads to alleviation of skin lesions and growth 
retardation. However, it must be noted that the restriction of dietary Ca did not allow complete 
recovery from the low concentration of serum Mg in Mg-deficient rats. The MCD rats remained Mg 
deficient. 
The MGD and MCD groups suffered severe Mg deficiency and the CAD and MCD groups 
suffered severe Ca deficiency in the present experiment because the Mg or Ca concentration in the 
deficient diets was set as low as 10% of the requirement levels. Mg or Ca deficiency shown in the 
present experiment may not take place actually. On the other hand, the Ca deficiency did not affect 
serum Ca concentration and body weight gain. These results suggest that Ca homeostasis is 
maintained in the Ca-deficient animals and the extent of Ca deficiency does not reach to induce 
pathological conditions in the present experiment. As reviewed by Nielsen(39), severe Mg deficiency 
induces many pathological conditions in experimental animals but subclinical Mg deficiency per se 
does not. On the other hand, severe Mg deficiency (14% of the requirement) increased hepatic Zn 
concentration within 10 days in rats and the increase in hepatic Zn concentration was also observed 
but delayed when rats suffered moderate Mg deficiency (22% of the requirement)(3). Therefore, we 
can postulate that MT and Zip14 mRNA expression is also up-regulated when rats are given a 
moderate Mg-deficient diet for long time.     
In conclusion, Mg and Ca deficiencies up-regulate MT expression in the liver through 
increasing Zn uptake by different mechanisms. Mg deficiency up-regulates Zip14 mRNA 
expression, and Ca deficiency increases the Zn supply from the bone to the liver. As a result, Mg 
and Ca deficiencies additively increase the expression of MT and the Zn concentrations in the liver. 
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Table 1.  Mineral concentration of the experimental diets (mmol/kg diet) 
 Diet 
 Control MGD CAD MCD 
Ca 136.3 131.7 13.1 13.2 
Mg   20.37   1.69 20.29  1.65 
Zn    0.61   0.61  0.61  0.61 
MGD, Mg-deficient; CAD, Ca-deficient; MCD, Mg- and Ca-deficient.
 12 
Table 2.  Sequence of the PCR primers for amplification 
Gene   Forward primer    Reverse primer        GenBank accession number 
MT-1 5’-CACCAGATCTCGGAATGGAC-3’    5’-GCAGCAGCTCTTCTTGCAG-3’       NM_138826 
MT-2 5’-ACCTCCTGCAAGAAAAGCTG-3’    5’-ACTTGTCCGAAGCCTCTTTG-3’       NM_001137564 
Zip1 5’-CCTGGCTACCTGTCTTCTGG-3’    5’-CTCTTGCAAGGGGAACTGAA-3’      NM_001134577 
Zip5 5’-CCTCGGGCCTAGACCTCTT-3’    5’-AGCTGGGAACCATTCAGACA-3’      NM_001108728 
Zip14 5’-TTCCTCAGTGTCTCACTGATTAA-3’   5’-GGAAAAGTGCGTTAGAGAGC-3’      NM_001107275 
ZnT1 5’-AACACCAGCAATTCCAACG-3’    5’-CCACTGGATCATCACTTCTCAA-3’      NM_022853 
ZnT5 5’-TGACACAAACATGCTGACACC-3’    5’-CATGACTGTGGGCGTGACT-3’       NM_001106404 
ZnT6 5’-GTGCCATCAACGTGCTGT-3’    5’-GGTGAGGTAAGTATAAGCAGTTAAAG-3’   NM_001106708 
Gapdh 5’-ACAACTTTGGCATCGTGGA-3’    5’-CTTCTGAGTGGCAGTGATGG-3’      NM_017008 
MT, metallothionein; Gapdh, glyceraldehyde-3-phosphate dehydrogenase. 
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Table 3. Effects of Mg and Ca deficiencies on growth parameters in rats 
(Mean values with their standard errors, n 6) 
Group Control   MGD   CAD   MCD     
Dietary Mg level Sufficient  Deficient  Sufficient  Deficient     
Dietary Ca level Sufficient   Sufficient   Deficient   Deficient  Effect (P =) 
  Mean SEM   Mean SEM   Mean SEM   Mean SEM   Mg  Ca Mg × Ca 
Initial body weight (g) 105.4 3.9  105.5 3.3  106.1 1.6  105.8 3.9  0.875 0.982 0.950 
Final body weight (g) 177.7 5.6  170.0 2.5  177.4 2.6  179.2 3.7  0.252 0.450 0.229 
Weight gain (g/d)   3.62a 0.15    3.23b 0.08    3.57a 0.11    3.67a 0.07  0.071 0.188 0.029 
Feed intake (g/d)  11.7 0.1   11.5 0.1   11.6 0.1   11.6 0.1  0.808 0.157 0.325 
Feed efficiency (g/g)   0.31a 0.01    0.28b 0.01     0.31a 0.01     0.32a 0.01   0.365 0.381 0.023 
 MGD, Mg deficient; CAD, Ca deficient; MCD, Mg and Ca deficient. 
When the interaction was significant, the significant differences among means were evaluated using Student-Newman-Keuls test; a,bmean values within 
a row with unlike superscript letters were significantly different (P < 0.05) among the 4 groups. 
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Table 4.  Effects of Mg and Ca deficiencies on mineral concentrations in serum and the amount of mineral in rat femur 
(Mean values with their standard errors, n 6) 
Group Control   MGD   CAD   MCD     
Dietary Mg level Sufficient  Deficient  Sufficient  Deficient     
Dietary Ca level Sufficient   Sufficient   Deficient   Deficient  Effect (P =) 
  Mean SEM   Mean SEM   Mean SEM   Mean SEM   Mg  Ca Mg × Ca 
Serum                
  Mg (µmol/L) 840b 33  226c* 12  1202a 80  313c* 25  <0.001 <0.001 0.008 
  Ca (mmol/L)    2.70  0.14    2.85  0.09     2.69  0.12    2.35  0.25  0.577 0.129 0.156 
  Zn ((µmol/L)  26.6  1.2   24.0  0.6    36.2  1.4   33.6  3.1  0.177 <0.001 0.962 
Femur                 
  Wet weight (g/femur)   0.71  0.03    0.84  0.04     0.66  0.04    0.69  0.04  0.056 0.009 0.264 
  Mg (µmol/femur)  44.4a  1.2   15.2c  0.8    29.6b  1.2   10.3d  0.8  <0.001 <0.001 <0.001 
  Ca (mmol/femur)   1.66  0.05    1.73  0.02     0.90  0.03    1.00  0.03  0.203 <0.001  0.716 
  Zn (µmol/femur)   1.39  0.06    1.42  0.02      1.14  0.04     1.36  0.07   0.007 0.026 0.086 
 MGD, Mg deficient; CAD, Ca deficient; MCD, Mg and Ca deficient.  
When an interaction was significant, the significant differences among means were evaluated using Student-Newman-Keuls test or the significant 
difference between 2 means was evaluated using the two-sided t-test; a,b,c,dmean values within a row with unlike superscript letters were significantly 
different (P < 0.05) among the 4 groups; *mean values were significantly different (P = 0.01) between the 2 groups. 
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Table 5. Effects of Mg and Ca deficiencies on Zn, metallothionein and thiobarbituric acid-reactive substances concentrations in rat liver 
(Mean values with their standard errors, n 6) 
Group Control   MGD   CAD   MCD     
Dietary Mg level Sufficient  Deficient  Sufficient  Deficient     
Dietary Ca level Sufficient   Sufficient   Deficient   Deficient  Effect (P =) 
  Mean SEM   Mean SEM   Mean SEM   Mean SEM  Mg  Ca Mg × Ca 
Wet weight (g/liver)  6.38 0.40    6.22 0.15    6.95 0.29    7.01  0.21  0.865 0.204 0.690 
Zn (μmol/g)  0.41 0.02    0.49 0.03    0.48 0.02    0.60  0.05  0.009 0.004 0.471 
Zn (μmol/liver)  2.63 0.13    3.04 0.12    3.31 0.15    4.18  0.29  0.003 <0.001 0.240 
MT protein (μg/g)  83.4 9.0  120.6 12.3  128.1 12.7  212.2 28.2  0.001 0.003 0.194 
TBARS (nmol/g)  45.4 3.2    52.8 1.7    42.7 5.7    53.8  4.5   0.034 0.834 0.658 
 MGD, Mg deficient; CAD, Ca deficient; MCD, Mg and Ca deficient; MT, metallothionein; TBARS, thiobarbituric acid-reactive substances.  
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Table 6.  Effects of Mg and Ca deficiencies on mRNA levels of MT and Zn transporters in rat liver 
(Mean values with their standard errors, n 6) 
Group Control   MGD   CAD   MCD     
Dietary Mg level Sufficient  Deficient  Sufficient  Deficient     
Dietary Ca level Sufficient   Sufficient   Deficient   Deficient  Effect (P =) 
 Mean SEM  Mean SEM  Mean SEM  Mean SEM  Mg  Ca Mg × Ca 
MT-1   1.00 0.31    6.87 2.53    5.30 1.23   12.24 3.23  <0.001 0.001 0.222 
MT-2   1.00 0.32   11.38 4.92    5.87 1.11   15.23 3.10  <0.001 <0.001 0.226 
Zip1   1.00 0.10    1.02 0.15    0.94 0.13    1.02 0.24  0.292 0.868 .0.533 
Zip5   1.00 0.55    0.62 0.10    1.53 0.54    1.00 0.13  0.068 0.907 0.668 
Zip14   1.00 0.14    1.42 0.22    1.07 0.18    1.75 0.18  0.014 0.383 0.659 
Znt1   1.00 0.18    0.90 0.09    0.92 0.12    1.11 0.23  0.759 0.494 0.481 
Znt5   1.00 0.15    1.10 0.09    1.05 0.19    1.15 0.12  0.690 0.553 0.940 
Znt6   1.00 0.10     0.85 0.11     0.75 0.20     0.71 0.08   0.537 0.111 0.463 
MGD, Mg deficient; CAD, Ca deficient; MCD, Mg and Ca deficient; MT, metallothionein.  


















Fig. 1.  Effects of Mg and Ca deficiencies on the inflammation score in the skin of rats 
Values are expressed as means with their SE (n 6). 
*Mean values were significantly different from the control and the Ca-deficient groups (P < 0.05).  
†Mean values were significantly different from the Mg and Ca- deficient group (P < 0.05).  
Lesions were not observed in the control group and the Ca-deficient group throughout the experimental period. 
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